Accenture Plc (ACN) Shares Bought by Aspiriant LLC

Aspiriant LLC grew its stake in Accenture Plc (NYSE:ACN) by 18.7% during the second quarter, HoldingsChannel reports. The firm owned 2,554 shares of the information technology services provider’s stock after buying an additional 403 shares during the quarter. Aspiriant LLC’s holdings in Accenture were worth $418,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Findlay Park Partners LLP boosted its stake in shares of Accenture by 18.3% in the 2nd quarter. Findlay Park Partners LLP now owns 3,384,829 shares of the information technology services provider’s stock valued at $553,724,000 after purchasing an additional 524,190 shares in the last quarter. Van Hulzen Asset Management LLC boosted its position in Accenture by 41.7% during the 2nd quarter. Van Hulzen Asset Management LLC now owns 13,366 shares of the information technology services provider’s stock worth $2,187,000 after buying an additional 3,935 shares during the period. Donaldson Capital Management LLC boosted its position in Accenture by 0.7% during the 2nd quarter. Donaldson Capital Management LLC now owns 192,788 shares of the information technology services provider’s stock worth $31,538,000 after buying an additional 1,362 shares during the period. Highland Private Wealth Management acquired a new stake in Accenture during the 2nd quarter worth approximately $221,000. Finally, Dynamic Advisor Solutions LLC boosted its position in Accenture by 51.8% during the 2nd quarter. Dynamic Advisor Solutions LLC now owns 19,183 shares of the information technology services provider’s stock worth $3,137,000 after buying an additional 6,543 shares during the period. Institutional investors own 69.61% of the company’s stock.

Several equities research analysts recently commented on the stock. Wolfe Research assumed coverage on shares of Accenture in a research report on Tuesday, July 17th. They set an “underperform” rating on the stock. Pivotal Research set a $180.00 target price on shares of Accenture and gave the stock a “buy” rating in a research report on Friday, June 29th. Credit Suisse Group lifted their target price on shares of Accenture from $151.00 to $160.00 and gave the stock a “neutral” rating in a research report on Friday, June 29th. BMO Capital Markets lifted their target price on shares of Accenture to $170.00 and gave the stock a “market perform” rating in a research report on Friday, June 29th. Finally, Citigroup lifted their target price on shares of Accenture from $159.00 to $163.00 and gave the stock a “neutral” rating in a research report on Friday, June 29th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $162.11.



In other news, General Counsel Chad T. Jerdee sold 1,141 shares of the business’s stock in a transaction that occurred on Monday, July 2nd. The shares were sold at an average price of $162.30, for a total value of $185,184.30. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Richard Lumb sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, July 20th. The stock was sold at an average price of $166.66, for a total transaction of $333,320.00. Following the completion of the transaction, the insider now owns 118,561 shares in the company, valued at approximately $19,759,376.26. The disclosure for this sale can be found here. Insiders sold a total of 54,357 shares of company stock worth $8,865,112 in the last 90 days. Corporate insiders own 0.21% of the company’s stock.

Shares of NYSE ACN opened at $161.24 on Wednesday. The company has a market capitalization of $108.41 billion, a PE ratio of 27.28, a PEG ratio of 2.32 and a beta of 0.96. Accenture Plc has a 52-week low of $127.26 and a 52-week high of $168.95.

Accenture (NYSE:ACN) last issued its quarterly earnings results on Thursday, June 28th. The information technology services provider reported $1.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.72 by $0.07. The firm had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.04 billion. Accenture had a net margin of 9.76% and a return on equity of 42.01%. The company’s revenue for the quarter was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.52 EPS. equities research analysts forecast that Accenture Plc will post 6.71 earnings per share for the current fiscal year.

Accenture Company Profile

Accenture plc provides consulting, technology, and outsourcing services worldwide. Its Communications, Media & Technology segment provides professional services that help clients accelerate and deliver digital transformation, and enhance business results through industry-specific solutions for communications, media, and high tech industries, as well as for software platforms.

Further Reading: What do I need to know about analyst ratings?

Want to see what other hedge funds are holding ACN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accenture Plc (NYSE:ACN).

Institutional Ownership by Quarter for Accenture (NYSE:ACN)

Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply